AN2 Therapeutics Inc (ANTX)

1.36 -0.04 (-2.86%) USD  |  NASDAQ  |  Dec 24, 16:00
More

AN2 Therapeutics Free Cash Flow Per Share (Annual)

Free Cash Flow Per Share (Annual) Chart

View Free Cash Flow Per Share (Annual) for ANTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Per Share (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Free Cash Flow Per Share (Annual) Range, Past 5 Years

View Free Cash Flow Per Share (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Per Share (Annual) Benchmarks

View Free Cash Flow Per Share (Annual) Benchmarks
Start Trial
Biomarin Pharmaceutical Inc Upgrade
Arbutus Biopharma Corp Upgrade
GlycoMimetics Inc Upgrade
FibroGen Inc Upgrade
Cidara Therapeutics Inc Upgrade